Mark M. Mendez

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of 5,175,000 depositary shares of Belden Inc. (the “Company”), each…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Universal American Corp. of an aggregate principal amount of $115 million of 4.00% convertible senior…

Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by Par Pacific Holdings, Inc. of $100 million aggregate principal amount of its 5.00% convertible…

Davis Polk advised the representatives of the several underwriters, in connection with an SEC-registered offering by Nevro Corp. of $172.5 million aggregate principal amount of its 1.75%…

Davis Polk advised the representative of the underwriters in connection with an SEC-registered offering by TimkenSteel Corporation of $75 million aggregate principal amount of its 6.00%…

Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The closing of the transaction, which is expected in the third quarter…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Knowles Corporation of $150 million aggregate principal amount of its 3.25%…

Davis Polk advised Anacor Pharmaceuticals, Inc. in connection with its offering of $287.5 million aggregate principal amount of its 2.00% convertible senior notes due 2023 to qualified…

Davis Polk is advising Atairos on its $250 million investment in Groupon. Under the terms of the investment, Atairos is purchasing $250 million in aggregate principal amount of 3.25%…

Davis Polk acted as counsel to an affiliate of the counterparty in connection with the execution of a forward sale agreement with Regency Centers Corporation relating to 3,100,000 shares of…